Vanguard Group’s bioAffinity Technologies BIAF Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.7K | Sell |
40,642
-136,255
| -77% | -$39.1K | ﹤0.01% | 4261 |
|
2025
Q1 | $46K | Sell |
176,897
-83,972
| -32% | -$21.8K | ﹤0.01% | 4196 |
|
2024
Q4 | $244K | Hold |
260,869
| – | – | ﹤0.01% | 4071 |
|
2024
Q3 | $543K | Buy |
260,869
+88,875
| +52% | +$185K | ﹤0.01% | 3953 |
|
2024
Q2 | $372K | Buy |
171,994
+101,668
| +145% | +$220K | ﹤0.01% | 4070 |
|
2024
Q1 | $142K | Buy |
70,326
+50,326
| +252% | +$102K | ﹤0.01% | 4212 |
|
2023
Q4 | $29.4K | Hold |
20,000
| – | – | ﹤0.01% | 4418 |
|
2023
Q3 | $23.3K | Buy |
+20,000
| New | +$23.3K | ﹤0.01% | 4485 |
|